Insulet Corp. (PODD) Acquisitions
The acquisitions for Insulet Corp. (PODD) is $0 with a year-over-year change of 0.00%. Acquisitions represent cash spent to acquire other businesses and show externally purchased growth activity.
PODD Acquisitions Chart
Reported annual fiscal-period values; no daily interpolation.
Current Acquisitions
$0
$0
Year-over-Year Change
0.00%
vs. $0 prior year
Historical Data
22
Years of data available
Annual Acquisitions History
| Year | Acquisitions | YoY Change | % Change |
|---|---|---|---|
| 2025 | $0 | +$0 | — |
| 2024 | $0 | $-3.00M | -100.00% |
| 2023 | $3.00M | $-23.00M | -88.46% |
| 2022 | $26.00M | +$26.00M | — |
| 2021 | $0 | +$0 | — |
| 2020 | $0 | +$0 | — |
| 2019 | $0 | +$0 | — |
| 2018 | $0 | +$0 | — |
| 2017 | $0 | $-5.71M | -100.00% |
| 2016 | $5.71M | +$999,000 | +21.19% |
| 2015 | $4.71M | +$4.71M | — |
| 2014 | $0 | +$0 | — |
| 2013 | $0 | +$0 | — |
| 2012 | $0 | $-37.85M | -100.00% |
| 2011 | $37.85M | +$37.85M | — |
| 2010 | $0 | +$0 | — |
| 2009 | $0 | +$0 | — |
| 2008 | $0 | +$0 | — |
| 2007 | $0 | +$0 | — |
| 2006 | $0 | +$0 | — |
| 2005 | $0 | +$0 | — |
| 2004 | $0 | — | — |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy